Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for its Agent Drug-Coated Balloon (DCB) for the treatment of coronary in-stent restenosis (ISR) in patients with coronary artery disease.

FDA approves Boston Scientific’s new drug-coated balloon for coronary in-stent restenosis

Interventional cardiologists have been anticipating this news for quite some time. The device, the first of its kind, provides an alternative treatment option to repeat PCI or cardiac surgery for patients with coronary ISR.

Nauman Mushtaq, MD, Northwestern Medicine, explains the value of CT coronary calcium scoring for patients and for the cardiology business model.

The many benefits of using low-cost CT coronary calcium scoring to screen patients

CT calcium scoring provides valuable evaluations of intermediate-risk patients in addition to making good business sense for hospitals. Nauman Mushtaq, MD, an interventional cardiologist with Northwestern, shared his own experience with this technology. 

cocaine heart failure HFrEF LVEF hospitalizations beta-blockers hypertension cardiology

MRI scans on rat brains could lead to new cocaine addiction therapies

A study on rat models reveals how prolonged cocaine use disrupts neural networks responsible for regulating emotions and problem solving.

Gen 2 Aria CV Pulmonary Hypertension System implanted in patient for first time.

World’s first patient treated with new implantable device for pulmonary hypertension

The procedure, performed on Feb. 14, was part of an early feasibility trial developed with help from the FDA.

healthcare business deal

Cardiologists partner with imaging AI specialists to improve care for high-risk heart patients

The new collaboration is designed to ensure patients who may face an increased risk of heart disease receive the follow-up care they need.

Biosense Webster gained CE mark approval for its Varipulse pulsed field ablation (PFA) system in Europe

Biosense Webster gains CE mark approval for new PFA system

The news represents yet another big regulatory approval for PFA technology in 2024. Could FDA approval be next for Biosense Webster?

Thumbnail

Fleischner Society updates thoracic radiology glossary, adds new terms and images

The glossary, first released in 1984, has not been updated since 2008.

Left, the FIRE1 heart failure remote monitoring device that gets implanted into the IVC to measure fluid volume status. Right, the external belt monitoring device worn by the patient that can alert clinicians about status changes so interventions can be done before a patient requires a hospital admission. 

Early feasibility study for implantable heart failure monitor moves forward 

Startup vendor FIRE1 completed patient enrollment in its U.S. early feasibility study for a heart failure remote monitoring device that directly measures fluid volume inside the IVC.

Displaying 777 - 784 of 5936
Design by Adaptive Theme